Errors involving medication dosage formulations are common and appear to present considerable risk to patients. This risk is expected to increase as more and more medications and medication dosage ...

AstraZeneca and MAP Pharmaceuticals Announce Worldwide Collaboration to Develop and Commercialize Unit Dose Budesonide; AstraZeneca to Pay $40 Million in Cash Upfront LONDON and MOUNTAIN VIEW, Calif., ...

Additionally, Content Uniformity (CU), which relies heavily on the proper blend uniformity of the final pharmaceutical product, must be verified for product release. During the development process, ...

HUMACAO, PR AND NEW YORK, NY / ACCESS Newswire / April 9, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery ...

HUMACAO, PR and NEW YORK, NY / ACCESS Newswire / April 29, 2025 / Aspire Biopharma Holdings, Inc. (ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery ...

Detailed particle characterization, including shape and size analysis and chemical identification, enables thorough understanding of drug formulations. This level of knowledge creates confidence and ...

Abstract and Introduction Characteristics and Contributors to Drug Formulation Errors Recommendations for Reducing Patient Risk From Errors With Dose Formulations Summary References Recommendations ...

Topline data from High-Dose Aspirin Trail anticipated early in 3Q with the potential to support an accelerated approval, subject to FDA feedback The Company expects to disclose topline data from its ...